通过变异性研究确定大麻素CB1受体的正基调节器结合部位
Hayley M Green1, Daniel M J Fellner2, David B Finlay1
1Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.
Pharmaceuticals (Basel, Switzerland)
|February 24, 2024
概括
针对大麻素CB1受体 (CB1) 的正基调制剂 (PAM) 提供了治疗潜力. 这项研究确定了关键的残留物和结合部位,揭示了ZCZ011部位对CB1的全激应作用至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 大麻素CB1受体 (CB1) 的正调节剂 (PAM) 呈现了治疗神经病痛和成的治疗策略,可能避免了orthosteric激活剂的不良影响.
- 了解CB1全调节的分子机制对于开发更安全的治疗方法至关重要.
研究的目的:
- 通过分子建模和突变发生,识别关键的氨基酸残留物和负责CB1 PAM活性的结合部位.
- 阐明已识别的全位在调解CB1受体功能的特定作用.
主要方法:
- 在分子建模中,预测可谓的全结合点.
- 在已识别的全囊内的关键残留物的位点定向突变发生.
- 功能性测试测量G蛋白解离和PAM活性,以应对各种配体.
主要成果:
- 确定了6个假定的全位,包括新的胆固醇结合位.
- ZCZ011的结合部位对于全激动性至关重要,突变取消了活性.
- 特定的残留物 (F191A3.27,I169A2.56) 对ZCZ011介导的全性激动症至关重要.
- GAT229的PAM活性依赖于多个残留物,表明复杂的全调节.
结论:
- 对CB1的度调节可能涉及多个结合位点的相互作用.
- ZCZ011位点是CB1全性激动的主要调解者.
- 对于设计有选择性的CB1 PAMs来说,对联体受体相互作用的详细理解至关重要.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K


